These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 8983559)
1. Breast reduction and carcinoma-in-situ. Villafane O; Stanley P; Venkataramakrishnan V Br J Plast Surg; 1996 Oct; 49(7):499. PubMed ID: 8983559 [No Abstract] [Full Text] [Related]
2. Reduction mammaplasty specimens and occult breast carcinomas. Kakagia D; Fragia K; Grekou A; Tsoutsos D Eur J Surg Oncol; 2005 Feb; 31(1):19-21. PubMed ID: 15642421 [TBL] [Abstract][Full Text] [Related]
3. Breast screening. Reality of ductal carcinoma in situ. Flanders J BMJ; 2009 Mar; 338():b958. PubMed ID: 19273513 [No Abstract] [Full Text] [Related]
4. Will ductal carcinoma in situ defeat breast cancer screening? Benson JR BMJ; 2009 Mar; 338():b957. PubMed ID: 19273512 [No Abstract] [Full Text] [Related]
5. A case of ductal carcinoma in situ of the breast. Yoshida M; Kinoshita T Jpn J Clin Oncol; 2009 Feb; 39(2):132. PubMed ID: 19155284 [No Abstract] [Full Text] [Related]
6. In situ and infiltrating ductal carcinoma arising in a breast hamartoma. Mester J; Simmons RM; Vazquez MF; Rosenblatt R AJR Am J Roentgenol; 2000 Jul; 175(1):64-6. PubMed ID: 10882247 [No Abstract] [Full Text] [Related]
7. In situ breast carcinoma: diagnosis and treatment. Hindle WH Clin Obstet Gynecol; 2002 Sep; 45(3):774-7. PubMed ID: 12370620 [No Abstract] [Full Text] [Related]
8. [Carcinoma in situ and invasive carcinoma within a breast hamartoma]. Franco Uliaque C; Pardo Berdun FJ Radiologia; 2010; 52(5):487-8. PubMed ID: 20863538 [No Abstract] [Full Text] [Related]
9. [Ductal carcinoma in situ of the breast]. Rueda Domínguez A; Alonso Muñoz MC; Gómez Gómez A; Ojeda González B Med Clin (Barc); 1993 Oct; 101(14):548-56. PubMed ID: 8231402 [No Abstract] [Full Text] [Related]
10. Magnetic resonance imaging in patients with ductal carcinoma in situ: routine, selective, or not at all? Margenthaler JA Ann Surg Oncol; 2014 May; 21(5):1510-1. PubMed ID: 24368563 [No Abstract] [Full Text] [Related]
11. Diagnostic issues with significant tumour displacement in breast biopsies. Lightfoot N; Tawfik B; Fox SB J Clin Pathol; 2014 Dec; 67(12):1110-1. PubMed ID: 25214055 [No Abstract] [Full Text] [Related]
13. Diagnosing breast disease. Chapman B CAP Today; 1998 Jul; 12(7):74, 76, 80 passim. PubMed ID: 10181880 [No Abstract] [Full Text] [Related]
14. Contralateral mastoplasty for breast reconstruction: a good opportunity for glandular exploration and occult carcinomas diagnosis. Petit JY; Rietjens M; Contesso G; Bertin F; Gilles R Ann Surg Oncol; 1997 Sep; 4(6):511-5. PubMed ID: 9309343 [TBL] [Abstract][Full Text] [Related]
16. Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry. Wells JM; Pipa J; Shin SJ Am J Surg Pathol; 2014 Mar; 38(3):434-5. PubMed ID: 24441664 [No Abstract] [Full Text] [Related]
17. The role of pre-operative diagnosis in breast cancer. Pinder SE; Elston CW; Ellis IO Histopathology; 1996 Jun; 28(6):563-6. PubMed ID: 8803604 [No Abstract] [Full Text] [Related]
18. Occasional FDG PET recognition of in situ breast cancer. Vincenzi B; Calvieri A; Santini D; Altomare V; Tonini G Ann Oncol; 2007 Sep; 18(9):1584-5. PubMed ID: 17761715 [No Abstract] [Full Text] [Related]